Private Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213K Sell
1,656
-48
-3% -$5.62K 0.01% 283
2026
Q1
$205K Buy
+1,704
New +$197K 0.01% 272
2022
Q1
Sell
-83,335
Closed -$6.39M 187
2021
Q4
$6.39M Buy
83,335
+20,463
+33% +$1.63M 1.2% 25
2021
Q3
$4.72M Buy
62,872
+6,551
+12% +$498K 1.15% 27
2021
Q2
$4.38M Sell
56,321
-4,857
-8% -$361K 1.1% 26
2021
Q1
$4.5M Sell
61,178
-8,348
-12% -$616K 1.29% 26
2020
Q4
$5.43M Buy
69,526
+8,566
+14% +$655K 1.79% 18
2020
Q3
$4.83M Buy
60,960
+938
+2% +$73.5K 1.94% 18
2020
Q2
$4.43M Buy
+60,022
New +$4.52M 1.81% 15

Other funds holding MRK

Private Advisory Group's MRK Position: Q2 2026 in Review

Private Advisory Group reduced its Merck (MRK) stake by 2.8% in Q2 2026, selling an estimated $5.62K and leaving 1,656 shares worth $213K. The position accounts for 0.01% of the portfolio, ranked #283.

Private Advisory Group first reported a position in MRK in Q2 2020 and has held it in 9 quarters since. The position peaked at $6.39M in Q4 2021. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Private Advisory Group held 1,656 shares of Merck worth $213K as of Q2 2026.
  • Private Advisory Group sold 48 Merck shares in Q2 2026, an estimated $5.62K.
  • Merck made up 0.01% of Private Advisory Group's portfolio in Q2 2026, its #283 holding.
  • Private Advisory Group first reported a position in Merck in Q2 2020 and has held it in 9 quarters since.
  • Private Advisory Group's Merck position peaked at $6.39M in Q4 2021.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Private Advisory Group's 13F filing for Q2 2026, filed 6 Aug 2026.